Apr 27, 2022
On April 13, 2022, ICER released its draft evidence report, “Betibeglogene Autotemcel for Beta Thalassemia.” This is the first step in ICER’s review process; ICER is scheduled to release a final report on this treatment in July 2022. Beta thalassemia is a disease...
Apr 21, 2022
Six small businesses from across the country were among the first companies ever to receive a national award for their innovative, outstanding employer-sponsored health program. The companies received the 2022 Health Plan Hero award in a ceremony recently held in the...
